research Culprits of Medication-Induced Telogen Effluvium, Part 1
Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.
Search
for
Sort by
Research
840-870 / 1000+ results research Systemic Minoxidil for Hair Disorders in Pediatric Patients: A Safety and Tolerability Review
Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.
research Amyloid-Associated Alopecia: A Reappraisal Including Its Pathophysiology
Amyloid deposits linked to a type of protein may cause a unique pattern of hair loss by disrupting hair growth cycles.
research Acute And Subacute Skin Manifestations Of Systemic Lupus Erythematosus Are Associated With An Earlier Response To Belimumab Than The Chronic Phenotype: Preliminary Data From The New Nation-Wide Cohort Of Belimumab In Real Life Setting Study—New Joint And Skin (BERLISS-NEJS)
Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.
research Juvenile RHUPUS Syndrome: A Case Report
RHUPUS should be considered in children with deforming arthritis.
research The Diagnosis and Treatment of Androgenetic Alopecia: A Review of the Most Current Management
Various treatments for common hair loss in men and women are effective, but should be tailored to individual needs and potential side effects.
research The Role of Topical Finasteride in Hair Loss Management: Current Evidence and Future Perspectives
Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.
research Nonpruritic Urticaria: A Sign of Serious Systemic Disease
Non-itchy rashes can indicate serious diseases like lupus.
research How Much Medication Is Delivered in a Novel Drug Delivery Technique Using a Tattoo Machine?
The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.
research Systemic Lupus Erythematosus in India: A Clinico-Serological Correlation
Early identification of lupus through skin signs and blood tests is crucial in India.
research Elucidating the Role of the Skin and Gut Microbiome in the Development and Pathogenesis of Alopecia Areata
Differences in skin and gut bacteria may contribute to alopecia areata.
research A Current Diagnostic and Therapeutic Challenge: Tinea Capitis
Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.
research Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review
Cannabinoids may help some skin conditions but more research is needed.
research Regulatory T Cells in Autoimmune Skin Diseases
Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.
research Pseudopelade of Brocq: A Review of a Rare Hair Disorder Leading to Cicatricial Alopecia
Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.
research Oral and Systemic Manifestations of Systemic Lupus Erythematosus: Exploring the Association
Oral ulcers are common in SLE patients and often link to other symptoms.
research Drug-Induced Lupus or Systemic Lupus Erythematosus After Experimental COVID-19 Therapy: Difficulties in Differential Diagnosis
Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.
research Facial Psoriasis Log-Based Area and Severity Index: A Valid and Reliable Severity Measurement Method Detecting Improvement of Facial Psoriasis in Clinical Practice Settings
The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.
research Targeting Potential of Zinc Oxide Nanoparticles and Finasteride-Loaded Nano Lipidic Carriers-Infused Topical Gel - In Vitro and In Vivo Skin Permeation Studies
Nanocarriers in gel may reduce side effects of oral hair loss treatments.
research Atypical Presentation of Systemic Lupus Erythematosus with Vasculitic Polyneuropathy
A rare form of lupus can cause severe nerve damage and other symptoms, but treatment can help.
research Serum Nuclear Factor E-2-Related Factor 2 in Female Pattern Hair Loss
Women with pattern hair loss may have more stress in their bodies due to a lack of NRF2, a protein. Eating healthy and losing weight could help reduce this stress and improve hair loss. NRF2 boosters might also help treat this type of hair loss.
research Diffuse Hair Loss in a Patient With Systemic Lupus Erythematosus
A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.
research Hair Loss and Androgen's Role in the Era of COVID-19
Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.
research Systemic Dexpanthenol as a Novel Treatment for Female Pattern Hair Loss
Dexpanthenol improves hair growth and satisfaction in women without side effects.
research The Quality of European Dermatological Guidelines: Critical Appraisal of the Quality of EDF Guidelines Using the AGREE II Instrument
European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.
research The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.
research Review of the Post-COVID-19 Syndrome Associated with Acute Telogen Effluvium
COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.
research Telogen Effluvium
Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.
research Post-Covid-19 Syndrome and Quality of Life Impairment in Severe Covid-19 Mexican Patients
Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.
research A Case of Dyschromatosis Universalis
Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.